Compare GSK Consumer with VENKYS (I) LIMITED - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs VENKYS (I) LIMITED - Comparison Results

GSK CONSUMER     Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER VENKYS (I) LIMITED GSK CONSUMER/
VENKYS (I) LIMITED
 
P/E (TTM) x 36.3 14.3 254.6% View Chart
P/BV x 10.7 2.7 402.4% View Chart
Dividend Yield % 0.8 0.5 175.8%  

Financials

 GSK CONSUMER   VENKYS (I) LIMITED
EQUITY SHARE DATA
    GSK CONSUMER
Mar-18
VENKYS (I) LIMITED
Mar-19
GSK CONSUMER/
VENKYS (I) LIMITED
5-Yr Chart
Click to enlarge
High Rs6,7934,725 143.8%   
Low Rs4,9191,787 275.3%   
Sales per share (Unadj.) Rs1,026.32,159.8 47.5%  
Earnings per share (Unadj.) Rs166.5123.6 134.7%  
Cash flow per share (Unadj.) Rs181.8144.4 125.9%  
Dividends per share (Unadj.) Rs75.008.00 937.5%  
Dividend yield (eoy) %1.30.2 521.3%  
Book value per share (Unadj.) Rs828.6625.6 132.4%  
Shares outstanding (eoy) m42.0614.09 298.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.71.5 378.5%   
Avg P/E ratio x35.226.3 133.5%  
P/CF ratio (eoy) x32.222.5 142.9%  
Price / Book Value ratio x7.15.2 135.8%  
Dividend payout %45.16.5 696.1%   
Avg Mkt Cap Rs m246,28445,874 536.9%   
No. of employees `0004.05.5 72.3%   
Total wages/salary Rs m5,2771,945 271.3%   
Avg. sales/employee Rs Th10,837.35,520.9 196.3%   
Avg. wages/employee Rs Th1,325.0352.8 375.5%   
Avg. net profit/employee Rs Th1,757.7315.9 556.4%   
INCOME DATA
Net Sales Rs m43,16530,431 141.8%  
Other income Rs m2,574290 887.3%   
Total revenues Rs m45,73930,721 148.9%   
Gross profit Rs m8,8343,084 286.4%  
Depreciation Rs m644294 219.3%   
Interest Rs m20316 6.4%   
Profit before tax Rs m10,7442,765 388.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,7431,024 365.6%   
Profit after tax Rs m7,0011,741 402.0%  
Gross profit margin %20.510.1 201.9%  
Effective tax rate %34.837.0 94.1%   
Net profit margin %16.25.7 283.4%  
BALANCE SHEET DATA
Current assets Rs m45,6208,904 512.4%   
Current liabilities Rs m17,4265,877 296.5%   
Net working cap to sales %65.39.9 656.7%  
Current ratio x2.61.5 172.8%  
Inventory Days Days3525 138.2%  
Debtors Days Days2437 64.3%  
Net fixed assets Rs m5,1385,675 90.5%   
Share capital Rs m421141 298.5%   
"Free" reserves Rs m34,4318,674 396.9%   
Net worth Rs m34,8518,815 395.4%   
Long term debt Rs m0399 0.0%   
Total assets Rs m54,12715,573 347.6%  
Interest coverage x530.29.8 5,430.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.82.0 40.8%   
Return on assets %13.013.2 98.2%  
Return on equity %20.119.8 101.7%  
Return on capital %30.933.4 92.4%  
Exports to sales %00.7 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA200 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,014200 1,505.5%   
Fx outflow Rs m186725 25.6%   
Net fx Rs m2,828-525 -538.9%   
CASH FLOW
From Operations Rs m7,2301,589 455.0%  
From Investments Rs m-4,465-383 1,166.6%  
From Financial Activity Rs m-3,634-1,204 301.8%  
Net Cashflow Rs m-8682 -41,338.1%  

Share Holding

Indian Promoters % 0.0 56.1 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 8.8 9.1%  
FIIs % 12.0 3.2 381.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 31.9 46.4%  
Shareholders   26,457 20,089 131.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   GODFREY PHILLIPS  DABUR  TATA GLOBAL  RASOYA PROTEINS  VADILAL INDUSTRIES  

Compare GSK CONSUMER With:   NESTLE (Switz.)  TIGER BRANDS (S. Africa)  COCA COLA (US)  AVI LTD. (S. Africa)  



Today's Market

Bank Credit Growth, World Bank on Developments in India, and Top Cues in Focus Today(Pre-Open)

On Thursday, Indian share markets rose sharply during closing hours and ended on a strong note, extending gains to the fifth day.

Related Views on News

VENKYS (I) LIMITED 2018-19 Annual Report Analysis (Annual Result Update)

Sep 16, 2019 | Updated on Sep 16, 2019

Here's an analysis of the annual report of VENKYS (I) LIMITED for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of VENKYS (I) LIMITED. Also includes updates on the valuation of VENKYS (I) LIMITED.

VENKYS (I) LIMITED Announces Quarterly Results (1QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Aug 7, 2019 | Updated on Aug 7, 2019

For the quarter ended June 2019, VENKYS (I) LIMITED has posted a net profit of Rs 618 m (down 13.0% YoY). Sales on the other hand came in at Rs 9 bn (up 19.7% YoY). Read on for a complete analysis of VENKYS (I) LIMITED's quarterly results.

GSK CONSUMER Announces Quarterly Results (1QFY20); Net Profit Up 23.8% (Quarterly Result Update)

Aug 5, 2019 | Updated on Aug 5, 2019

For the quarter ended June 2019, GSK CONSUMER has posted a net profit of Rs 2 bn (up 23.8% YoY). Sales on the other hand came in at Rs 12 bn (up 7.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (4QFY19); Net Profit Up 34.9% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 34.9% YoY). Sales on the other hand came in at Rs 13 bn (up 9.0% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

VENKYS (I) LIMITED Announces Quarterly Results (4QFY19); Net Profit Down 41.5% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, VENKYS (I) LIMITED has posted a net profit of Rs 299 m (down 41.5% YoY). Sales on the other hand came in at Rs 8 bn (up 11.8% YoY). Read on for a complete analysis of VENKYS (I) LIMITED's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Oct 17, 2019 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 5-YR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS